FDA OKs new drug for heavy periods
Lysteda approved as first non-hormonal way to reduce menstrual bleeding
 | Women's health videos |
 Women don't work out hard enough, docs say Nov. 27: A woman's metabolism is nearly one-third slower than a man's, and that's why doctors say many women can exercise and still not lose weight. KNSD's Catherine Garcia reports. |
Most popular |
| |||||
updated 4:36 p.m. ET Nov. 13, 2009
WASHINGTON - Federal health officials have approved a new drug as the first non-hormonal treatment for heavy menstrual bleeding.
The Food and Drug Administration says Lysteda tablets reduce bleeding by acting on a protein that helps blood clot. The drug is made by Newport, Ky.-based Xanodyne Pharmaceuticals.
The main ingredient in the drug was first approved in 1986 as an injection for patients with hemophilia, an inheritable disease that prevents blood clotting.
The FDA warns that taking Lysteda with hormonal contraceptive drugs can increase the risk of blood clots, stroke and heart attacks. Women should only use the products together if there is a strong medical need, the agency says.
Copyright 2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
- Discuss Story On Newsvine
-
Rate Story:
View popularLowHigh - Instant Message
MORE FROM WOMEN'S HEALTH |
 Women's health Section Front |
| Add Women's health headlines to your news reader: |